Pharmacokinetics of Mycophenolic Acid Following Enteric-Coated Mycophenolate Sodium Administration in Chinese Renal Transplant Recipients.

被引：0

作者：

Peng, W. ^{[1
]}

Tian, C. ^{[1
]}

Chen, Z. ^{[1
]}

Xue, W. ^{[1
]}

Wang, G. ^{[1
]}

Ye, Q. ^{[1
]}

Zhang, X. ^{[1
]}

Gu, M. ^{[1
]}

Zhao, M. ^{[1
]}

Wang, C. ^{[1
]}

Huang, C. ^{[1
]}

Yan, J. ^{[1
]}

Zhang, W. ^{[1
]}

Ding, C. ^{[1
]}

Fu, Y. ^{[1
]}

Ye, S. ^{[1
]}

Hu, X. ^{[1
]}

Tan, R. ^{[1
]}

Li, M. ^{[1
]}

Deng, R. ^{[1
]}

Ke, Y. ^{[1
]}

Wu, W. ^{[1
]}

Fan, M. ^{[1
]}

Chen, J. ^{[1
]}

机构：

[1] MyERA Study Grp, Hangzhou, Zhejiang, Peoples R China

来源：

AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

C114

引用

页码：806 / 807

页数：2

共 50 条

[21] Mycophenolic Acid and Metabolite Pharmacokinetics in African American (AA) and Caucasian (C) Renal Transplant Recipients Receiving Enteric Coated Mycophenolic Sodium and Mycophenolate Mofetil
Tornatore, Kathleen M.
Sudchada, Patcharaporn
DiFrancesco, Robin A.
Gundroo, Aijaz
Gray, Vanessa
Attwood, Kris
Wilding, Greg
Venuto, Rocco C.
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 295 - 295
[22] Gastrointestinal Quality of Life Improvement of Renal Transplant Recipients Converted From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Drugs or Agents: Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium
Ortega, Francisco
Sanchez-Fructuoso, Ana
Maria Cruzado, Jose
Carlos Gomez-Alamillo, Juan
Alarcon, Antonio
Pallardo, Lluis
Maria Morales, Jose
Oliver, Juan
Guinea, Guillermo
TRANSPLANTATION, 2011, 92 (04) : 426 - 432
[23] Enteric-coated mycophenolate sodium: Safe conversion from mycophenolate mofetil in maintenance renal transplant recipients
Budde, K
Glander, P
Diekmann, F
Dragun, D
Waiser, J
Fritsche, L
Neumayer, HH
TRANSPLANTATION PROCEEDINGS, 2004, 36 (02) : 524S - 527S
[24] A study about the safety and tolerability of the conversion to enteric-coated mycophenolate sodium from Mycophenolate Mofetil in stable pediatric renal transplant recipients.
David-Neto, E
Turconi, A
Giron, F
Adragna, M
Otero, A
Pereira, ML
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 575 - 575
[25] A Review of Enteric-coated Mycophenolate Sodium for Renal Transplant Immunosuppression
Newbold, Nathan
Riley, Brianna
Hardinger, Karen
CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 927 - 933
[26] Limited Sampling Strategy for Mycophenolic Acid in Chinese Kidney Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium and Tacrolimus During the Early Posttransplantation Phase
Yao, Xi
Huang, Hongfeng
Wei, Chunchun
Chen, Ying
Peng, Wenhan
Xie, Wenqing
Chen, Jianghua
THERAPEUTIC DRUG MONITORING, 2015, 37 (04) : 516 - 523
[27] Enteric-coated mycophenolate sodium for transplant immunosuppression
Ingle, GR
Shah, T
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (21) : 2252 - 2259
[28] Safety assessment of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable renal transplant recipients
Massari, P
Duro-Garcia, V
Girón, F
Hernández, E
Juárez, F
Castro, C
Toledo, M
TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 916 - 919
[29] Adequate Early Mycophenolic Acid (MPA) Exposure Achieved by Initially Intensified Dosing Regimen of Enteric-Coated Mycophenolate Sodium (EC-MPS) in De Novo Renal Transplant Recipients.
Arns, W.
Sommerer, C.
Tedesco-Silva, H.
Contieri, F.
Kuypers, D.
Vaidya, S.
Budde, K.
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 395 - 396
[30] Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant recipients with gastrointestinal tract disorders
Darji, P.
Vijayaraghavan, R.
Thiagarajan, C. M.
Sharma, R. K.
Subbarao, B.
Pishardy, R.
Dakshinamurthy, K. V.
Vijaykumar, R.
Abraham, G.
Bhaskar, S.
Agarwal, L.
Shah, B.
Abraham, A.
John, M.
Sampathkumar, K.
Das, T.
Umesh, L.
Sundar, S.
Ballal, H.
Jasuja, S.
Saxena, S.
Saha, T. K.
TRANSPLANTATION PROCEEDINGS, 2008, 40 (07) : 2262 - 2267

← 1 2 3 4 5 →